Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.
Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against ne...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5875805?pdf=render |
| _version_ | 1819074169812287488 |
|---|---|
| author | Takuma Matsumura Jiro Terada Taku Kinoshita Yoriko Sakurai Misuzu Yahaba Kenji Tsushima Seiichiro Sakao Kengo Nagashima Toshinori Ozaki Yoshio Kobayashi Takaki Hiwasa Koichiro Tatsumi |
| author_facet | Takuma Matsumura Jiro Terada Taku Kinoshita Yoriko Sakurai Misuzu Yahaba Kenji Tsushima Seiichiro Sakao Kengo Nagashima Toshinori Ozaki Yoshio Kobayashi Takaki Hiwasa Koichiro Tatsumi |
| author_sort | Takuma Matsumura |
| collection | DOAJ |
| description | Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA.Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated.NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO2 and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA.Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further. |
| first_indexed | 2024-12-21T18:05:15Z |
| format | Article |
| id | doaj.art-18fbbccdb9614536a181089c4d53609b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T18:05:15Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-18fbbccdb9614536a181089c4d53609b2022-12-21T18:54:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019501510.1371/journal.pone.0195015Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.Takuma MatsumuraJiro TeradaTaku KinoshitaYoriko SakuraiMisuzu YahabaKenji TsushimaSeiichiro SakaoKengo NagashimaToshinori OzakiYoshio KobayashiTakaki HiwasaKoichiro TatsumiAlthough severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA.Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated.NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO2 and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA.Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further.http://europepmc.org/articles/PMC5875805?pdf=render |
| spellingShingle | Takuma Matsumura Jiro Terada Taku Kinoshita Yoriko Sakurai Misuzu Yahaba Kenji Tsushima Seiichiro Sakao Kengo Nagashima Toshinori Ozaki Yoshio Kobayashi Takaki Hiwasa Koichiro Tatsumi Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. PLoS ONE |
| title | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| title_full | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| title_fullStr | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| title_full_unstemmed | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| title_short | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| title_sort | circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 nbl1 a potential biomarker for coronary artery disease in patients with obstructive sleep apnea |
| url | http://europepmc.org/articles/PMC5875805?pdf=render |
| work_keys_str_mv | AT takumamatsumura circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT jiroterada circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT takukinoshita circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT yorikosakurai circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT misuzuyahaba circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT kenjitsushima circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT seiichirosakao circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT kengonagashima circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT toshinoriozaki circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT yoshiokobayashi circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT takakihiwasa circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea AT koichirotatsumi circulatingautoantibodiesagainstneuroblastomasuppressoroftumorigenicity1nbl1apotentialbiomarkerforcoronaryarterydiseaseinpatientswithobstructivesleepapnea |